MFIM
RLAY icon

Mesirow Financial Investment Management’s Relay Therapeutics RLAY Stock Holding History

Mesirow Financial Investment Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-32,916
Closed -$84.6K – 597
2025
Q1 		$84.6K Hold
32,916
– – ﹤0.01% 567
2024
Q4 		$136K Buy
32,916
+18,380
+126% +$100K ﹤0.01% 565
2024
Q3 		$103K Buy
+14,536
New +$109K ﹤0.01% 569

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mesirow Financial Investment Management's RLAY Position: Q2 2025 in Review

Mesirow Financial Investment Management sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 32,916 shares — an estimated $84.6K sold.

Mesirow Financial Investment Management first reported a position in RLAY in Q3 2024 and held it in 3 quarters. The position peaked at $136K in Q4 2024. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • Mesirow Financial Investment Management reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 32,916 Relay Therapeutics shares in Q2 2025, an estimated $84.6K.
  • Mesirow Financial Investment Management first reported a position in Relay Therapeutics in Q3 2024 and held it in 3 quarters.
  • Mesirow Financial Investment Management's Relay Therapeutics position peaked at $136K in Q4 2024.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on Mesirow Financial Investment Management's 13F filing for Q2 2025, filed 4 Aug 2025.